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Functional telomeres are critical for stem cell prolifer-
ation; however, whether they are equally important
for the stability of stem cell differentiation is not
known. We found that mouse embryonic stem
cells (ESCs) with critically short telomeres (Tert/
ESCs) initiated normal differentiation after leukemia
inhibitory factor (LIF) withdrawal but, unlike control
ESCs, failed to maintain stable differentiation
when LIF was reintroduced to the growth medium.
Tert/ ESCs expressed higher levels of Nanog
and, overall, had decreased genomic CpG methyla-
tion levels, which included the promoters of Oct4
and Nanog. This unstable differentiation phenotype
could be rescued by telomere elongation via reintro-
duction of Tert, via suppression of Nanog by small
hairpin RNA (shRNA) knockdown, or via enforced
expression of the de novo DNA methyltransferase
3b. These results demonstrate an unexpected role
of functional telomeres in the genome-wide epige-
netic regulation of cell differentiation and suggest
a potentially important role of telomere instability in
cell fate during development or disease.
INTRODUCTION
Murine embryonic stem cells (ESCs) are self-renewing, pluripo-
tent cells able to differentiate into cells of all three germ layers.
Pluripotency and self-renewal are maintained primarily by the
core transcriptional factors Nanog, Oct4, and Sox2 (Heng
et al., 2010) but require both the cooperation of other factors
and coregulators (Li, 2010) and an efficient telomere mainte-
nance mechanism (Huang et al., 2011). In mammals, telomere
maintenance is achieved via a telomerase reverse transcriptase
(Tert) and an integral RNA component (Terc) that synthesize
new telomeric DNA during cell proliferation. An appropriate
telomere maintenance system is important for ESC replicative
potential (Agarwal et al., 2010; Batista et al., 2011; Marion
et al., 2009). During the reprogramming of differentiated cells
into stem cells, an increase in telomerase activity leads to telo-
mere elongation and the acquisition of epigenetic marks charac-teristic of longer telomeres (Marion et al., 2009). Notably, the
teratoma-forming ability of ESCs derived from late generation
(G3–G4) Terc/ mice with critically short telomeres is greatly
reduced (Huang et al., 2011).
RESULTS
Critically Short Telomeres in ESCs Lead to Elevated
Basal Levels of Nanog
We sought to address the impact of telomere dysfunction not
only upon the capacity for cell differentiation but also upon the
maintenance of a differentiated state. Late-passage Tert/
ESCs (Tert/S) (Liu et al., 2000) that possessed shorter telo-
meres and a significant accumulation of telomere signal-free
ends relative to wild-type (WT) ESCs or Tert/ cells at earlier
passages (Tert/L) (Figures S1A–S1C available online; p <
0.0001; Fisher’s exact test) were nonetheless proliferation-
competent and did not exhibit an altered doubling time, cell
morphology, or cell-cycle distribution (Figures S1D and
S1E; data not shown). However, Nanog messenger RNA
(mRNA) and protein levels were significantly elevated (Figures
1A–1C and S1F–S1G). No difference was observed in Oct4,
Sox2, and Klf4 expression (Figures 1C and S1F). To test whether
the difference in Nanog expression was related to telomere
dysfunction, we reintroduced WT Tert into late-passage Tert/
ESCs (Tert/R), and, after the propagation of clonal lines ex-
pressing Tert, we observed the reparation of telomere signal-
free ends and a restoration of Nanog levels closer to the levels
observed in WT ESCs and Tert/ ESCs at early passage
(Figures 1A–1D, S1A–S1C, S1F, and S1G). Transient expression
of Tert for 72 hr, a period of time insufficient to permit telomere
extension, failed to restore Nanog to levels comparable to WT
ESCs (data not shown). These data suggest that the dysregula-
tion of Nanog in Tert/S ESCs is a consequence of critically
short telomeres.
ESCs that express high levels of Nanog tend to self-renew,
whereas cells that express low levels of this factor tend to differ-
entiate (Chambers et al., 2007; Savarese et al., 2009; Singh et al.,
2007). Immunofluorescence analysis of Tert/S ESCs cultured
on gelatin in leukemia inhibitory factor (LIF)-containing media
revealed a significant increase in the percentage of Nanoghigh
cells in comparison to WT and Tert/R ESCs (Figures 1A and
S1G) (Savarese et al., 2009). We confirmed elevated Nanog
expression in Tert/S ESCs via fluorescence-activated cell
sorting (FACS) analysis (Figure 1B). We also measured theCell Stem Cell 12, 479–486, April 4, 2013 ª2013 Elsevier Inc. 479
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Figure 1. Analysis of Pluripotency Factors in WT and Tert–/– ESCs
(A) Quantification of Nanog levels normalized over DAPI (see Figure S1G for corresponding immunofluorescence images). Note a significant shift (p < 0.0001) from
Nanog-low (DAPI to Nanog-488 R 1.8) to Nanog-high (DAPI to Nanog-488 < 1.5) cells in Tert/S in comparison to WT and Tert/R ESCs (n R 100 per cell
population).
(B) FACS analysis of the Nanog expression profile in the same genotypes as in (A). Note the rightward shift and increase in average Nanog signal intensity in
Tert/S ESCs.
(C) Relative gene expression analyzed by qRT-PCR, normalized to GAPDH (n = 4). Data are represented as mean ± SD.
(D) (Top) Nanog protein expression with LI-COR quantification below (n = 3). Data are represented as mean ± SD; L, long telomeres (passage 30); S, short
telomeres (passage 70); R, Tert rescue (70 passages, followed by clonal selection and an additional 4 passages after Tert reintroduction). The superscripts 1 and 2
indicate two independently generated Tert/R colonies.
(E) ChIP analysis using an antibody to H3K27me3 and H3K4me3. Relative enrichment was quantified with the use of region-specific qPCR primers for Nanog,
Oct4, and Gata6 promoters. Generic IgG was used as a control (n = 3). Data are represented as mean ± SD. *, p < 0.05; **, p < 0.01; ***, p < 0.0001.
See also Figure S1 and Table S1.
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Short Telomeres Affect ESC Differentiationexpression of other factors involved in the pluripotency regula-
tory network (Rex1, Esrrb, and Tbx3) (Festuccia et al., 2012; Iva-
nova et al., 2006; Shi et al., 2006), including pluripotency factors
that negatively regulate Nanog expression (Zfp281) (Fidalgo
et al., 2011) and lineage differentiation markers (Cdx2) and the
endoderm markers (Gata6 and Gata4) that are negatively regu-
lated by Nanog (Singh et al., 2007). As anticipated, Rex1, Esrrb,
and Tbx3 mRNA levels were increased in Tert/S ESCs,
whereas Zpf281 and Cdx2 levels were unaffected (Figure 1C).480 Cell Stem Cell 12, 479–486, April 4, 2013 ª2013 Elsevier Inc.However, Gata6 and Gata4 were also increased (Figure 1C).
Consistent with these observations, chromatin immunoprecipi-
tation (ChIP) analysis revealed lower levels of Nanog occupancy
on the Gata6 promoter (Figure S1I). Nevertheless, the recruit-
ment of Nanog to its own promoter, which represses its own
expression (Fidalgo et al., 2011), increased in Tert/S ESCs
(Figure S1I). Thus, the increased expression of Nanog is not
a consequence of the impaired occupancy of Nanog on its
own promoter.
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Critically Short Telomeres
Telomere attrition is associated with the loss of certain hetero-
chromatin markers and DNA hypomethylation at telomeric and
subtelomeric regions (Benetti et al., 2007). We postulated that
the increase in Nanog expression could be linked to a general
dysregulation of epigenetic repression, given that low levels of
trimethylation on histone H3 lysine 27 (H3K27me3) promote
Nanog and Gata6 expression (Lu et al., 2011; Shen et al., 2008;
Villasante et al., 2011). H3K27me3 was reduced at Nanog and
Gata6 promoters in Tert/S ESCs, whereas H3K4me3 levels at
the Nanog promoter were unaffected (Figure 1E). H3K27me3
and H3K4me3 enrichment on theOct4 promoter was unaffected
(Figure 1E). These perturbations, including a slightly increased
level of global H3K27me3 in Tert/S ESCs, were restored upon
telomere elongation (Figures 1E and S1H). These changes were
not accompanied by a significant alteration in the three-dimen-
sional localization of telomere DNA or chromatin in interphase
nuclei (Figure S1J). Thus, the altered expression of Nanog and
Gata6 reflects changes in heterochromatin at their respective
promoters independent of Nanog occupancy. Moreover, these
results demonstrate that critically short telomeres also affect
chromatin organization at loci distal to telomeres.
Critically Short Telomeres Perturb the Ability of ESCs
to Remain Stably Differentiated
The impact of Nanog misregulation upon differentiation was
tested by treating ESCs with 5 mM all-trans retinoic acid
(ATRA), which was followed by the removal of ATRA and the
readdition of LIF-containing media (Figure 2). Although longer
ATRA treatment times were required to achieve suppression of
Oct4, Nanog, and Sox2 mRNA and protein to levels comparable
to WT or Tert/ ESCs with longer telomeres (Figures 2A2D
and S2), Tert/S ESCs nevertheless exhibited a low proliferative
capacity after ATRA treatment, which was consistent with
a differentiated state (Figure 2E). However, after the readdition
of LIF-containingmedia, Tert/S ESCs failed tomaintain repres-
sion of Nanog and exhibited robust colony formation only 6 days
after the readdition of LIF-containing media (Figures 2 and S2).
As an independent marker of differentiation, WT and Tert/S
cells were transduced with an Oct4 promoter-driven green fluo-
rescent protein (GFP) construct, treated with ATRA for 12 days,
and then sorted to allow the selection of the GFP-negative pop-
ulation by FACS. Sorted GFP-negative cells were plated in the
presence of LIF-containing media for 10 days, followed by an
assessment of the percentage of GFP-positive cells. Tert/S
cells exhibited a high percentage of GFP-positive cells after
the readdition of LIF-containing media (Figure 2F). These results
demonstrate that ESCs with telomere dysfunction were able to
execute only an incomplete, transitory repression of pluripo-
tency genes in response to differentiation cues.
ESCs with Short Telomeres Exhibit DNA
Hypomethylation
Critically short telomeres are associated with DNA hypomethyla-
tion at subtelomeric DNA (Benetti et al., 2007). Given that we
observed chromatin alterations at loci distal to telomeres, we
tested whether Tert/S ESCs also exhibited altered DNA meth-
ylation throughout the genome. Bisulphite-sequencing analysisof the Nanog and Oct4 promoters revealed a significant reduc-
tion in the acquisition of methylated cytosine in Tert/S ESCs
treated with ATRA relative to WT or Tert/R ESCs (p % 0.01
and p < 0.0001, respectively; Fisher’s exact test) (Figure 3A).
Furthermore, Tert/S ESCs failed to maintain even this level of
cytosine methylation after the readdition of the LIF-containing
media (p < 0.0001 and p = 0.03, respectively). At both promoters,
this impairment was rescued in Tert/R ESCs (p > 0.05; Fig-
ure 3A). Genome-wide methylation measured by an ELISA-
based detection system against methylcytosine was also
significantly reduced in Tert/S ESCs (Figure 3B). Nonspecific
epigenetic drift appeared improbable, given that WT and
Tert/R ESCs did not exhibit these changes after a similar prop-
agation period. Although ESCs can tolerate DNA hypomethyla-
tion without impairment of cell proliferation (Tsumura et al.,
2006), hypomethylation nonetheless impairs the capability of
ESCs to achieve, and maintain a differentiated state (Feldman
et al., 2006; Jackson et al., 2004; Sinkkonen et al., 2008). Thus,
DNA hypomethylation in Tert/S ESCs arose in response to crit-
ically short telomeres and impeded their stable differentiation.
Restoration of Dnmt3b or Depletion of Nanog Rescue
the Stable Differentiation of ESCs with Short Telomeres
We tested whether the restoration of DNA methylation might
restore the differentiation capability of Tert/S ESCs. In
mammals, genomic DNA methylation is principally regulated
by three DNA methyltransferases (Dnmts): Dnmt1 (methylation
maintenance) and the de novo methyltransferases Dnmt3a and
Dnmt3b (Li et al., 1992; Okano et al., 1999). Although Dnmt1
expression was unaffected in Tert/S ESCs, the expression of
de novo methylases was reduced (Figure 3C). Enforced expres-
sion of Dnmt3b in Tert/S ESCs restored repression of Nanog
(Figures 3D, 3E, and S3(A) and restored the repression ofNanog,
Oct4, and Sox2 mRNA upon ATRA treatment (Figures 4A and
4B). Dnmt3b expression also led to a significant reduction in
the colony formation of Tert/S ESCs after the readdition of
LIF-containing media (Figure 4C). The level of H3K27me3 at
the Nanog promoter was also partially rescued in Tert/S
ESCs that expressed elevated Dnmt3b (Figure 4D). Consistent
with a direct role of Nanog suppression in the maintenance of
stable differentiation, Nanog depletion by small hairpin RNA
(shRNA) was sufficient to overcome the inability of Tert/S
ESCs to remain differentiated (Figure 4C), and all genotypes
transduced with Nanog shRNA exhibited a decrease in pluripo-
tency gene expression (Figure S4). These results demonstrate
that the mechanism of impaired ability to maintain stable differ-
entiation in Tert/S ESCs acts via the perturbation of de novo
DNA methylation, which, in turn, influences chromatin organiza-
tion and the ability to repress pluripotency factors such asNanog
under differentiation conditions.
DISCUSSION
Here, we report that critically short telomeres led to genome-
wide DNA hypomethylation and that changes in H3K27 trimethy-
lation occurred at loci distal to telomeres. The trimethylation of
H3K27 is mediated by the polycomb repressive complex 2
(PRC2) and is associated with ESC identity (Shen et al., 2008).
H3K27me3 is one of the principal histone repression markers,Cell Stem Cell 12, 479–486, April 4, 2013 ª2013 Elsevier Inc. 481
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Figure 2. Differentiation Analysis of Tert–/– ESCs
(A) Bright field images of ESC populations at day 0 and day 6 inmedia containing 5 mMall-trans retinoic acid (ATRA) and, after ATRA removal, an additional 6 days
in LIF-containing media. The micrograph bar indicates 200 mm for bright field images and15 mm for immunofluorescence images.
(B) Nanog immunofluorescence analysis (green, Nanog; red, Actin).
(C) Nanog protein detection by western blot. Tub, b-tubulin (n = 3).
(D) qRT-PCR analysis of pluripotency genes after ATRA-induced differentiation. Gene expression at day 0 was arbitrarily set as 100, and the expression through
the time course was normalized to mRNA levels at day 0. Values were expressed as a ratio to GAPDH.
(E) Single-colony formation assay after ATRA treatment (6 days) is shown, and, where indicated, the readdition of LIF-containingmedia (6 days) (n = 3) is shown. The
difference in the incidence of colony formation betweenTert/S (after LIF readdition) and all theother genotypes (orTert/Swithout LIF)was statistically significant
(p<0.0001;ANOVAandrelatedDunnett’s testcomparingeverygroupwithTert/Svalues). Theyaxis indicatescolonynumber.Dataare representedasmean±SD.
(F) Oct4-promoter-driven GFP expression analysis of WT and Tert/S ESCs post-ATRA treatment and after cell sorting for GFP-negative cells. The y axis
indicates the percentage of GFP-positiveWT, or Tert/ cells after 12 days of ATRA treatment and FACS sorting (FACS; columns 1 and 3) and after the readdition
of LIF-containing media to GFP-negative sorted cells (columns 2 and 4). The difference in the incidence of GFP-positive cells between Tert/S andWT cells was
statistically significant (p < 0.00001; Welch’s unpaired t test). Data are represented as mean ± SD.
See also Figure S2.
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Short Telomeres Affect ESC Differentiationand its diminished enrichment on Nanog and Gata6 promoters
has been linked to the upregulation of these genes (Kim et al.,
2008; Lu et al., 2011; Shen et al., 2008; Villasante et al., 2011).
Although the global level of H3K27me3 increased in Tert/S
ESCs similar to recent studies that associate H3K27me3
enrichment with unmethylated CpG islands, its presence at
Nanog and Gata6 promoters was reduced (Lynch et al., 2012;
Mendenhall et al., 2010). These data support the observation482 Cell Stem Cell 12, 479–486, April 4, 2013 ª2013 Elsevier Inc.that DNA hypomethylation leads to overall increased levels of
H3K27me3 in normally methylated regions but decreased levels
of H3K27me3 in ordinarily unmethylated regions (Brinkman
et al., 2012). Our data suggest a model whereby telomere-short-
ening-induced de novo Dnmt downregulation leads to DNA
hypomethylation and altered H3K27me3 enrichment at pro-
moters, which, in turn, affects the ability to repress pluripotency
factors critical to stable differentiation in ESCs (Figure 4E).
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Figure 3. Expression of DNA Methyltransferases in ESCs Lacking Tert
(A) CpG methylation analysis of the Oct4 and Nanog promoters during ATRA treatment, followed by culture in LIF-containing media. Each column represents
CpGs in a sequenced clone. Full dots symbolize methylated CpGs, and empty dots symbolize unmethylated CpGs. Percentage values indicate the proportion of
methylated cytosine relative to total cytosine residues (n = 10).
(B) Relative quantification of global DNA methylation (n = 3) is shown. Data are represented as mean ± SD.
(C) Relative gene expression of Dnmt1, Dnmt3b, and Dnmt3a2 analyzed by qRT-PCR. Values were normalized to GAPDH (n = 4). Data are represented as
mean ± SD.
(D) (Top) Dnmt3b protein detection by western blot and (bottom) after LI-COR quantification (n = 3). Data are represented as mean ± SD.
(E) Nanog protein detection by western blot. Tub, b-tubulin (n = 5); R, Tert rescue; 3b,Dnmt3b rescue. Passage numbers are as in Figure 1. *, p < 0.05; **, p < 0.01;
***, p < 0.0001.
See also Figure S3.
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Short Telomeres Affect ESC DifferentiationThe regulation of factors that affect pluripotency and differen-
tiation are important not only to development but also to disease.
For example, pluripotency factors such as Nanog tend to be
highly expressed in undifferentiated tumors and in putative
cancer stem cells (Tysnes, 2010). In addition, some cancer ther-
apies employ differentiation-inducing agents such as retinoic
acid in the treatment of acute promyelocytic leukemia (Petrie
et al., 2009). Thus, it will be important to test whether critically
short telomeres also influence cell fate in human cancer cells,
particularly in the case of telomerase-inhibition strategies de-
signed to instigate telomere instability.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
All experiments employed two separately generated ESC lines containing
a disruption of endogenous Tert, as previously described (Liu et al., 2000).
ESC lines were cultured on gelatin-covered dishes and maintained in Glas-
gow’s Modified Eagle’s Medium (GMEM; GIBCO) supplemented with15% v/v fetal bovine serum (FBS), 0.055 mM b-mercaptoethanol (Sigma-
Aldrich), 2 mM L-glutamine, 0.1 mM GMEM nonessential amino acids,
5,000 units/ml penicillin and streptomycin, 1,000 units/ml of recombinant
LIF (Chemicon), and 1 mg/ml doxycycline and maintained at 37C with 5%
v/v CO2. To restore Tert expression to Tert
/S ESCs cells at passage, we
cotransfected 70, ESCs with pTRE-Bi-Tert-IRES-EGFP-Hygro (or a similar
vector lacking Tert) and CAG-rtTA advanced (pTET-ON advanced vector;
Clontech). For constitutive expression of Tert, Tert/S ESCs were trans-
fected with CAG-mTert-IRES-Puro or CAG-IRES-Puro. For expression of
Dnmt3b, Tert/S ESCs were transfected with CAG-Dnmt3b-IRES-Puro or
CAG-IRES-Puro. All transfections employed Fugene 6 (Roche) in a 3:1 ratio
to DNA according to the manufacturer’s instructions. For Tert rescue or
Dnmt3b reintroduction, cells were propagated for four passages under
selection with hygromycin (500 mg/ml) or puromycin (5 mg/ml), and individual
colonies were isolated. For Nanog shRNA transduction, cells were infected
with commercially available lentiviral particles (Santa Cruz Biotechnology)
and selected with puromycin (5 mg/ml). Cell transduction with Oct4-promoter
GFP was performed by infection with commercially available lentiviral parti-
cles (System Biosciences). All lentiviral infections were performed in the
presence of Polybrene (5 mg/ml; Santa Cruz Biotechnology). All experiments
were performed with more than one clonal isolate.Cell Stem Cell 12, 479–486, April 4, 2013 ª2013 Elsevier Inc. 483
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Figure 4. Differentiation Ability of Tert–/– ESCs after Enforced Expression of Dnmt3b
(A) Nanog protein detection by western blot. Tub, b-tubulin (n = 3). The first two panels on the left are reproduced from Figure 2C.
(B) qRT-PCR analysis of pluripotency genes upon ATRA-induced differentiation. Gene expression at day 0 was arbitrarily set as 100 and the expression through
the time course was normalized to mRNA levels at day 0. Values were expressed as a ratio to GAPDH. The first two genotypes were reproduced from Figure 2D.
(C) Single-colony formation assay after the removal of ATRA and the readdition of LIF-containingmedia (n = 3). The difference in the incidence of colony formation
between Tert/S and all the other genotypes, apart from short hairpin control-transduced Tert/s cells, was statistically significant (p < 0.0001; ANOVA and
related Dunnett’s test comparing every group with Tert/S values). The y axis indicates colony number. Data are represented as mean ± SD.
(D) Chromatin immunoprecipitation analysis of H3K27me3 enrichment at the Nanog promoter, as described in Supplemental Experimental Procedures. Data are
represented as mean ± SD (n = 3). *, p < 0.05; **, p < 0.01; ***, p < 0.0001.
(E) A schematic showing that telomere shortening impairs the expression of Dnmt3 isoforms, leading to genome-wide DNA hypomethylation, which, in turn,
affects H3K27me3 enrichment on specific loci (e.g., Nanog), thus impairing the ability of ESCs to sustain pluripotency factor repression after differentiation and
growth restimulation.
See also Figure S4.
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Short Telomeres Affect ESC DifferentiationDifferentiation Assay
Cell populations of the indicated genotype (13 105) were plated in non-gelatin-
covered dishes in LIF-freemedia containing 5 mMATRA (Sigma-Aldrich) for the
indicated amount of time with ATRA-media replaced every 3 days. At the
indicated time point, cells were replated in gelatin-covered dishes with
LIF-containing media. For the single colony formation assay, a set of serial
dilutions was performed, and the number of viable ES cell colonies was
assessed with alkaline phosphatase (Millipore).
Quantitative Fluorescence In Situ Hybridization
The quantitative fluorescence in situ hybridization (Q-FISH) protocol was
carried out as described previously (Liu et al., 2000). Metaphase spreads
were captured with the use of Metafer 4 software and analyzed with Isis484 Cell Stem Cell 12, 479–486, April 4, 2013 ª2013 Elsevier Inc.software. Statistical analysis of telomere intensity distribution was performed
with Welch’s unpaired t test. The incidence of telomere signal-free ends was
defined as the number of chromosome ends possessing a telomere signal
(in arbitrary units) between 0 and 600, and statistical significance was as-
sessed with Fisher’s exact test (InStat 3, GraphPad).
qRT-PCR
Total RNA was isolated from cells with the use of Triazol (Invitrogen) according
to the manufacturer’s instructions. Reverse transcription was carried out with
the use of 0.5 mg of template RNA, random hexamer primers, and smart MMLV
reverse transcriptase (Clontech). Diluted complementary DNA (203) was
subjected to real-time PCR analysis using a SYBR Green Master Mix (Roche)
on a LightCycler 480 system (Roche). Background values (no reverse
Cell Stem Cell
Short Telomeres Affect ESC Differentiationtranscriptase added) were subtracted and values were normalized to glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) (n > 3). The oligos employed
are listed in Table S1. Statistical analysis was performed by ANOVA and
a related Dunnett’s test comparing every group with WT values.
ChIP Sequencing
ChIP experiments were performed as described in Bergmann et al., 2011,
except phenol-chloroform was replaced with a Chelex, 100-based DNA isola-
tionmethod described in Nelson et al., 2006. Recovered DNAwas analyzed by
qRT-PCR as described above. For each pair of primers, triplicate measure-
ments were taken and normalized to input DNA and the amount of DNA recov-
ered from the GAPDH promoter (n > 3). Antibodies employed were as follows:
rabbit anti-Nanog (Bethyl Laboratories); mouse anti-H3K27me3 and anti-
H3K4me3 (Abcam); and murine IgG (Sigma-Aldrich). Oligos employed are
listed in Table S1. Statistical analysis was performed by ANOVA and a related
Dunnett’s test comparing every group with WT values. In each experiment, the
signal present after immunoprecipitation with IgG was defined as background
and subtracted prior to normalization to input DNA and GAPDH.
Methylation Assay
Relative genomic DNA methylation was assessed with the use of the ELISA-
based Imprint Methylated DNA Quantification kit (Sigma-Aldrich) according
to the manufacturer’s instructions, with the use of 100 ng of genomic DNA
per sample (n > 3).
Bisulphite Sequencing Analysis
DNA bisulphite conversion was performed as described previously (Clouaire
et al., 2010). After bisulphite conversion of unmethylated cytosines to uracil,
samples were resuspended in 1 3 Tris–EDTA for PCR amplification. PCR
products were cloned into pcDNA3.1 Directional TOPO Expression (Invitro-
gen) vector and colony PCR was performed. Clones (at least ten per sample)
of the correct molecular mass were sequenced, and results were analyzed
with BiQ Analyzer (http://biq-analyzer.bioinf.mpi-inf.mpg.de). Primers em-
ployed are listed in Table S1. Statistical analysis of samples employed Fisher’s
exact test (two-sided) using GraphPad InStat3 (www.graphpad.com).
SUPPLEMENTAL INFORMATION
Supplemental Information contains Supplemental Experimental Procedures,
four figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.stem.2013.01.018.
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